1. Ortner, Nadine J. . CACNA1D-Related Channelopathies: From Hypertension to Autism. In Handbook of experimental pharmacology, 279, 183-225. doi:10.1007/164_2022_626. https://pubmed.ncbi.nlm.nih.gov/36592224/
2. Stanton, Ana Maria, Heydarpour, Mahyar, Williams, Jonathan S, Williams, Gordon H, Adler, Gail K. 2023. CACNA1D Gene Polymorphisms Associate With Increased Blood Pressure and Salt Sensitivity of Blood Pressure in White Individuals. In Hypertension (Dallas, Tex. : 1979), 80, 2665-2673. doi:10.1161/HYPERTENSIONAHA.123.21229. https://pubmed.ncbi.nlm.nih.gov/37846579/
3. Scholl, Ute I. 2022. Genetics of Primary Aldosteronism. In Hypertension (Dallas, Tex. : 1979), 79, 887-897. doi:10.1161/HYPERTENSIONAHA.121.16498. https://pubmed.ncbi.nlm.nih.gov/35139664/
4. Pinggera, Alexandra, Striessnig, Jörg. 2016. Cav 1.3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders. In The Journal of physiology, 594, 5839-5849. doi:10.1113/JP270672. https://pubmed.ncbi.nlm.nih.gov/26842699/
5. Giri, Dinesh, Hawton, Katherine, Senniappan, Senthil. 2021. Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management. In Journal of pediatric endocrinology & metabolism : JPEM, 35, 279-296. doi:10.1515/jpem-2021-0369. https://pubmed.ncbi.nlm.nih.gov/34547194/